Information  X 
Enter a valid email address

Renalytix AI PLC (RENX)

  Print      Mail a friend

Monday 21 January, 2019

Renalytix AI PLC

Clarification re. lock-up restrictions

RNS Number : 5675N
Renalytix AI PLC
21 January 2019

Renalytix AI plc

("Renalytix" or the "Company")


Clarification re. lock-up restrictions for Distribution Shares


This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the "Distribution Shares").  


Holders of Distribution Shares are reminded that these shares remain subject to a lock-up restriction until 22 April 2019. To avoid settlement issues and potentially having to repurchase such shares in the market, such persons should therefore avoid attempting to sell Distribution Shares until Tuesday, 23 April 2019 or afterwards.


For further information, please contact:


Renalytix AI plc

James McCullough, CEO

Via Walbrook PR or Tel: +1 646 397 3970



N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / James White / George Tzimas (Corporate Finance)
Tom Salvesen
/ Mia Gardner (Corporate Broking)








Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303












This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t